Astrana Health (NASDAQ:ASTH – Free Report) had its target price hoisted by Truist Financial from $37.00 to $38.00 in a research report report published on Friday,Benzinga reports. Truist Financial currently has a buy rating on the stock. Several other research analysts have also commented on the company. Weiss Ratings reiterated a “sell (d+)” rating on […]